Critical Role of Endogenous Thrombospondin-1 in Preventing Expansion of Healing Myocardial Infarcts
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Background— Matricellular proteins are extracellular matrix proteins that do not contribute directly to tissue integrity but are capable of modulating cell function. We hypothesized that the matricellular protein thrombospondin (TSP)-1, a potent inhibitor of angiogenesis and activator of transforming growth factor (TGF-β), is induced in healing myocardial infarcts and plays a role in suppressing the postinfarction inflammatory response, inhibiting local angiogenesis, and limiting expansion of granulation tissue into the noninfarcted area. Methods and Results— We used a canine and a murine model of reperfused infarction. TSP-1 mRNA was induced in canine infarcts after 1 hour of ischemia and 3 to 7 days of reperfusion. TSP-1 protein showed a strikingly selective localization in the extracellular matrix, microvascular endothelium, and a subset of mononuclear cells of the infarct border zone after 5 to 28 days of reperfusion. Isolated canine venous endothelial cells showed low-level constitutive expression of TSP-1 mRNA, which was markedly induced by TGF-β, and basic fibroblast growth factor. Murine infarcts also had marked TSP-1 deposition in the border zone. Infarcted TSP-1 −/− mice exhibited sustained upregulation of the chemokines monocyte chemoattractant protein-1, macrophage inflammatory protein-1α, and interferon-γ–inducible protein-10/CXCL10 and the cytokines interleukin-1β, interleukin-6, and TGF-β, suggesting an enhanced and prolonged postinfarction inflammatory response. In addition, TSP-1 −/− mice had markedly increased macrophage and myofibroblast density in infarcts and in remodeling noninfarcted myocardial areas neighboring the myocardial scar, suggesting expansion of granulation tissue formation into the noninfarcted territory. TSP-1 −/− animals had more extensive postinfarction remodeling than wild-type mice, although infarct size was similar in both groups. Conclusions— The infarct border zone may be capable of modulating the healing process through its unique extracellular matrix content. The selective endogenous expression of TSP-1 in the infarct border zone may serve as a “barrier,” limiting expansion of granulation tissue and protecting the noninfarcted myocardium from fibrotic remodeling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Points of control in inflammation
Nathan, C. (2002) · Nature · doi:10.1038/nature01320 · Cited by 2,738
The inflammatory response in myocardial infarction
Frangogiannis, N. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00434-5 · Cited by 2,011
Self-citationThrombospondin-1 Is a Major Activator of TGF-β1 In Vivo
Crawford, S. E., Stellmach, V., Murphy-Ullrich, J. E., Ribeiro, S. M. F., Lawler, J., Hynes, R. O., Boivin, G. P., & Bouck, N. (1998) · Cell · doi:10.1016/s0092-8674(00)81460-9 · Cited by 1,174
Self-citationInflammatory Cytokines and Postmyocardial Infarction Remodeling
Nian, M., Lee, P., Khaper, N., & Liu, P. (2004) · Circulation Research · doi:10.1161/01.res.0000130526.20854.fa · Cited by 1,028
Matricellular proteins: extracellular modulators of cell function
Bornstein, P., & Sage, E. H. (2002) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(02)00361-7 · Cited by 965
Heymans, S., Luttun, A., Nuyens, D., Theilmeier, G., Creemers, E., Moons, L., Dyspersin, G. D., Cleutjens, J. P. M., Shipley, M., Angellilo, A., et al. (1999) · Nature Medicine · doi:10.1038/13459 · Cited by 794
Activation of latent TGF-β by thrombospondin-1: mechanisms and physiology
Murphy-Ullrich, J. E., & Poczatek, M. (2000) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(99)00029-5 · Cited by 586
Tolsma, S., Volpert, O., Good, D., Frazier, W., Polverini, P., & Bouck, N. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.2.497 · Cited by 573
Frangogiannis, N. G., Lindsey, M. L., Michael, L. H., Youker, K. A., Bressler, R. B., Mendoza, L. H., Spengler, R. N., Smith, C. W., & Entman, M. L. (1998) · Circulation · doi:10.1161/01.cir.98.7.699 · Cited by 511
Self-citationThe de-adhesive activity of matricellular proteins: is intermediate cell adhesion an adaptive state?
Murphy-Ullrich, J. E. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12609 · Cited by 476
Cited by
The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis
Prabhu, S. D., & Frangogiannis, N. G. (2016) · Circulation Research · doi:10.1161/circresaha.116.303577 · Cited by 2,224
Self-citationThe inflammatory response in myocardial injury, repair, and remodelling
Frangogiannis, N. G. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.28 · Cited by 1,738
Self-citationThe pathogenesis of cardiac fibrosis
Kong, P., Christia, P., & Frangogiannis, N. G. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1349-6 · Cited by 1,567
Self-citationFrangogiannis, N. G. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvaa324 · Cited by 1,229
Self-citationRegulation of the Inflammatory Response in Cardiac Repair
Frangogiannis, N. G. (2012) · Circulation Research · doi:10.1161/circresaha.111.243162 · Cited by 1,194
Self-citationSpinale, F. G. (2007) · Physiological Reviews · doi:10.1152/physrev.00012.2007 · Cited by 1,120
Transforming growth factor (TGF)-β signaling in cardiac remodeling
Dobaczewski, M., Chen, W., & Frangogiannis, N. G. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.10.033 · Cited by 934
Self-citationThe role of TGF-β signaling in myocardial infarction and cardiac remodeling
BUJAK, M., & FRANGOGIANNIS, N. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.10.002 · Cited by 927
Self-citationCardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities
Frangogiannis, N. G. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.07.001 · Cited by 841
Self-citationThe immune system and cardiac repair
FRANGOGIANNIS, N. (2008) · Pharmacological Research · doi:10.1016/j.phrs.2008.06.007 · Cited by 641
Self-citationPathophysiology of Myocardial Infarction
Frangogiannis, N. G. (2015) · Comprehensive Physiology · doi:10.1002/cphy.c150006 · Cited by 618
Self-citationTGF-β and fibrosis in different organs — molecular pathway imprints
Pohlers, D., Brenmoehl, J., Löffler, I., Müller, C. K., Leipner, C., Schultze-Mosgau, S., Stallmach, A., Kinne, R. W., & Wolf, G. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.06.004 · Cited by 576
Dobaczewski, M., Gonzalez-Quesada, C., & Frangogiannis, N. G. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.07.015 · Cited by 548
Self-citationThe extracellular matrix in myocardial injury, repair, and remodeling
Frangogiannis, N. G. (2017) · Journal of Clinical Investigation · doi:10.1172/jci87491 · Cited by 524
Self-citationThe Extracellular Matrix in Ischemic and Nonischemic Heart Failure
Frangogiannis, N. G. (2019) · Circulation Research · doi:10.1161/circresaha.119.311148 · Cited by 520
Self-citationRedox Signaling in Cardiac Physiology and Pathology
Burgoyne, J. R., Mongue-Din, H., Eaton, P., & Shah, A. M. (2012) · Circulation Research · doi:10.1161/circresaha.111.255216 · Cited by 482
Adams, J. C., & Lawler, J. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009712 · Cited by 457
Self-citationMatricellular Proteins in Cardiac Adaptation and Disease
Frangogiannis, N. G. (2012) · Physiological Reviews · doi:10.1152/physrev.00008.2011 · Cited by 445
Self-citationExtracellular matrix remodeling and cardiac fibrosis
Li, L., Zhao, Q., & Kong, W. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.01.013 · Cited by 419
Fibroblasts in the Infarcted, Remodeling, and Failing Heart
Humeres, C., & Frangogiannis, N. G. (2019) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2019.02.006 · Cited by 410
Self-citationWan, E., Yeap, X. Y., Dehn, S., Terry, R., Novak, M., Zhang, S., Iwata, S., Han, X., Homma, S., Drosatos, K., et al. (2013) · Circulation Research · doi:10.1161/circresaha.113.301198 · Cited by 383
Inflammation and fibrosis in murine models of heart failure
Bacmeister, L., Schwarzl, M., Warnke, S., Stoffers, B., Blankenberg, S., Westermann, D., & Lindner, D. (2019) · Basic Research in Cardiology · doi:10.1007/s00395-019-0722-5 · Cited by 382
Myocardial Extracellular Matrix: An Ever-Changing and Diverse Entity
Rienks, M., Papageorgiou, A.-P., Frangogiannis, N. G., & Heymans, S. (2014) · Circulation Research · doi:10.1161/circresaha.114.302533 · Cited by 366
Self-citationInterleukin-1 Receptor Type I Signaling Critically Regulates Infarct Healing and Cardiac Remodeling
Bujak, M., Dobaczewski, M., Chatila, K., Mendoza, L. H., Li, N., Reddy, A., & Frangogiannis, N. G. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070974 · Cited by 365
Self-citationEssential Role of Smad3 in Infarct Healing and in the Pathogenesis of Cardiac Remodeling
Bujak, M., Ren, G., Kweon, H. J., Dobaczewski, M., Reddy, A., Taffet, G., Wang, X.-F., & Frangogiannis, N. G. (2007) · Circulation · doi:10.1161/circulationaha.107.704197 · Cited by 356
Self-citationMacrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets
Chen, R., Zhang, H., Tang, B., Luo, Y., Yang, Y., Zhong, X., Chen, S., Xu, X., Huang, S., & Liu, C. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01840-1 · Cited by 349
Transforming growth factor-β in myocardial disease
Frangogiannis, N. G. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00646-w · Cited by 344
Self-citationHeymans, S., Hirsch, E., Anker, S. D., Aukrust, P., Balligand, J.-L., Cohen-Tervaert, J. W., Drexler, H., Filippatos, G., Felix, S. B., Gullestad, L., et al. (2009) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfn043 · Cited by 323
The role of IL-1 in the pathogenesis of heart disease
Bujak, M., & Frangogiannis, N. G. (2009) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-009-0024-y · Cited by 307
Self-citationDobaczewski, M., Xia, Y., Bujak, M., Gonzalez-Quesada, C., & Frangogiannis, N. G. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090759 · Cited by 301
Self-citationCardiac Oxidative Stress and Inflammatory Cytokines Response after Myocardial Infarction
Neri, M., Fineschi, V., Paolo, M., Pomara, C., Riezzo, I., Turillazzi, E., & Cerretani, D. (2015) · Current Vascular Pharmacology · doi:10.2174/15701611113119990003 · Cited by 294
Role of cytokines and inflammation in heart function during health and disease
Bartekova, M., Radosinska, J., Jelemensky, M., & Dhalla, N. S. (2018) · Heart Failure Reviews · doi:10.1007/s10741-018-9716-x · Cited by 293
Frangogiannis, N. G., Dewald, O., Xia, Y., Ren, G., Haudek, S., Leucker, T., Kraemer, D., Taffet, G., Rollins, B. J., & Entman, M. L. (2007) · Circulation · doi:10.1161/circulationaha.106.646091 · Cited by 289
Self-citationThe Mechanistic Basis of Infarct Healing
Frangogiannis, N. G. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.1907 · Cited by 288
Self-citationNoma, H., Funatsu, H., Yamasaki, M., Tsukamoto, H., Mimura, T., Sone, T., Hirayama, T., Tamura, H., Yamashita, H., Minamoto, A., et al. (2008) · Eye · doi:10.1038/sj.eye.6702498 · Cited by 283
Thrombospondin-1: Multiple Paths to Inflammation
Lopez-Dee, Z., Pidcock, K., & Gutierrez, L. S. (2011) · Mediators of Inflammation · doi:10.1155/2011/296069 · Cited by 283
Anti‐inflammatory therapies in myocardial infarction: failures, hopes and challenges
Huang, S., & Frangogiannis, N. G. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14155 · Cited by 282
Self-citationChemokines in ischemia and reperfusion
Frangogiannis, N. (2007) · Thrombosis and Haemostasis · doi:10.1160/th07-01-0022 · Cited by 276
Self-citationPhysiological Implications of Myocardial Scar Structure
Richardson, W. J., Clarke, S. A., Quinn, T. A., & Holmes, J. W. (2015) · Comprehensive Physiology · doi:10.1002/cphy.c140067 · Cited by 268
Cavalera, M., Wang, J., & Frangogiannis, N. G. (2014) · Translational Research · doi:10.1016/j.trsl.2014.05.001 · Cited by 267
Self-citationRuiz-Villalba, A., Romero, J. P., Hernández, S. C., Vilas-Zornoza, A., Fortelny, N., Castro-Labrador, L., San Martin-Uriz, P., Lorenzo-Vivas, E., García-Olloqui, P., Palacio, M., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.044557 · Cited by 260
Ai, X., Yu, P., Peng, L., Luo, L., Liu, J., Li, S., Lai, X., Luan, F., & Meng, X. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.762654 · Cited by 218
Extracellular matrix remodeling in canine and mouse myocardial infarcts
Dobaczewski, M., Bujak, M., Zymek, P., Ren, G., Entman, M. L., & Frangogiannis, N. G. (2006) · Cell and Tissue Research · doi:10.1007/s00441-005-0144-6 · Cited by 180
“In contrast, studies of dermal fibroblasts demonstrated that collagen matrix promotes a relatively quiescent phenotype attenuating the collagen synthetic response of fibroblasts to TGF-β (Clark et al. 1995).”
BackgroundSelf-citationHilgendorf, I., Frantz, S., & Frangogiannis, N. G. (2024) · Circulation Research · doi:10.1161/circresaha.124.323658 · Cited by 180
Self-citationFrangogiannis, N. G. (2014) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000003 · Cited by 165
“Thrombospondin 1, a potent angiostatic protein with a crucial role in TGF-b activation, is selectively upregulated in the infarct border zone and suppresses the inflammatory reaction, serving as a barrier that prevents the extension of inflammatory activity into the viable noninfarcted myocardium.(80) Other matricellu…”
BackgroundSelf-citationBär, C., de Jesus, B. B., Serrano, R., Tejera, A., Ayuso, E., Jimenez, V., Formentini, I., Bobadilla, M., Mizrahi, J., de Martino, A., et al. (2014) · Nature Communications · doi:10.1038/ncomms6863 · Cited by 162
The role of Smad signaling cascades in cardiac fibrosis
Hanna, A., Humeres, C., & Frangogiannis, N. G. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109826 · Cited by 132
Self-citationEffects of diet-induced obesity on inflammation and remodeling after myocardial infarction
Thakker, G. D., Frangogiannis, N. G., Bujak, M., Zymek, P., Gaubatz, J. W., Reddy, A. K., Taffet, G., Michael, L. H., Entman, M. L., & Ballantyne, C. M. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00322.2006 · Cited by 121
“The picrosirius-stained slides were scanned using a Zeiss Axioskop microscope, and quantitative evaluation was performed using ImagePro software (23).”
MethodSelf-citationSuppression of thrombospondin-1–mediated inflammaging prolongs hematopoietic health span
Ramalingam, P., Gutkin, M. C., Poulos, M. G., Winiarski, A., Smith, A., Carter, C., Doughty, C., Tillery, T., Redmond, D., Freire, A. G., et al. (2025) · Science Immunology · doi:10.1126/sciimmunol.ads1556 · Cited by 17
Metadata
- Authors
- Frangogiannis, N. G., Ren, G., Dewald, O., Zymek, P., Haudek, S., Koerting, A., Winkelmann, K., Michael, L. H., Lawler, J., & Entman, M. L.
- Venue
- Circulation
- Published
- 2005-06-07
- Volume
- 111
- Issue
- 22
- Pages
- 2935-2942
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1968264871
- Cited by
- 308
- References
- 32
- FWCI
- 8.70
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.